The Wellcome Trust is funding a new study and clinical trial that will further investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis. Work carried out by Oxford University and King’s College London will look at whether CBD can be used not only to treat established psychosis, but also to prevent the onset of psychosis in people at high risk of developing it.
Is CBD the future of antipsychotic drugs? | News | Wellcome
Source: The King’s Fund
This report finds that by moving towards community-powered health –working collaboratively with communities as equal partners in the design and delivery of health care – can help make prevention a reality, protect the NHS’s future and improve health for all.
This report highlights that tackling preventable illness must remain a top priority for the government in the 2020s. More than half of the disease burden in England is deemed preventable, with one in five deaths attributed to causes that could have been avoided. It goes on to argue that any prevention strategy must take into account the way information can be used to promote public health and spread information.
